Hasija Amit, CFO and EVP of Corporate Development at Milestone Pharmaceuticals Inc. ($MIST), sold shares on the open market twice in the last year, totaling about $158 thousand. The most recent sale occurred on January 26, 2026. These sales rank 8,882nd among nearly 12 thousand individual insiders in our database, where the average is $8.6 million across about 6.4 transactions. Amit made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Milestone Pharmaceuticals Inc. | $MIST | Hasija Amit | CFO & EVP of Corp. Development | A | Employee Stock Option (right to buy) | 204000 | $0.00 | 204,000.0000 | 85,169,344 | 9999.99% | 0.24% |
| Feb. 2, 2026 | Milestone Pharmaceuticals Inc. | $MIST | Hasija Amit | CFO & EVP of Corp. Development | A | Restricted Stock Unit | 136000 | $0.00 | 136,000.0000 | 85,169,344 | 9999.99% | 0.16% |
| Feb. 2, 2026 | Milestone Pharmaceuticals Inc. | $MIST | Hasija Amit | CFO & EVP of Corp. Development | A | Employee Stock Option (right to buy) | 204000 | $0.00 | 204,000.0000 | 85,169,344 | 9999.99% | 0.24% |
| Dec. 15, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Hasija Amit | CFO & EVP of Corp. Development | S | Common Shares | 58007 | $2.32 | 91,993.0000 | 85,169,344 | 38.67% | 0.07% |
| Dec. 12, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Hasija Amit | CFO & EVP of Corp. Development | A | Common Shares | 100000 | $0.00 | 150,000.0000 | 85,169,344 | 200.00% | 0.12% |
| Jan. 26, 2026 | Milestone Pharmaceuticals Inc. | $MIST | Hasija Amit | CFO & EVP of Corp. Development | M | Common Shares | 20100 | $0.00 | 112,093.0000 | 85,169,344 | 21.85% | 0.02% |
| Jan. 26, 2026 | Milestone Pharmaceuticals Inc. | $MIST | Hasija Amit | CFO & EVP of Corp. Development | S | Common Shares | 12245 | $1.93 | 99,848.0000 | 85,169,344 | 10.92% | 0.01% |
| Dec. 12, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Hasija Amit | CFO & EVP of Corp. Development | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 85,169,344 | 9999.99% | 0.12% |
| Jan. 26, 2026 | Milestone Pharmaceuticals Inc. | $MIST | Hasija Amit | CFO & EVP of Corp. Development | M | Restricted Stock Units | 20100 | $0.00 | 60,300.0000 | 85,169,344 | 25.00% | 0.02% |
| July 11, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Hasija Amit | CFO & EVP of Corp. Development | A | Series B Common Warrants (right to buy) | 50000 | $0.00 | 50,000.0000 | 53,464,273 | 9999.99% | 0.09% |
| July 11, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Hasija Amit | CFO & EVP of Corp. Development | A | Common Shares | 50000 | $0.00 | 50,000.0000 | 53,464,273 | 9999.99% | 0.09% |
| July 11, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Hasija Amit | CFO & EVP of Corp. Development | A | Series A Common Warrants (right to buy) | 50000 | $0.00 | 50,000.0000 | 53,464,273 | 9999.99% | 0.09% |
| Jan. 27, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Hasija Amit | CFO & EVP of Corp. Development | A | Employee Stock Option (right to buy) | 120600 | $0.00 | 120,600.0000 | 53,327,908 | 9999.99% | 0.23% |
| Jan. 27, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Hasija Amit | CFO & EVP of Corp. Development | A | Restricted Stock Unit | 80400 | $0.00 | 80,400.0000 | 53,327,908 | 9999.99% | 0.15% |
| Feb. 16, 2023 | Milestone Pharmaceuticals Inc. | $MIST | Hasija Amit | CFO & EVP of Corp. Development | A | Employee Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 34,286,002 | 9999.99% | 0.38% |